Literature DB >> 12880208

The role of c-Jun N-terminal kinase (JNK) in Parkinson's disease.

Jun Peng1, Julie K Andersen.   

Abstract

Given the critical role that the c-Jun N-terminal kinase (JNK) pathway plays in regulating many of the cellular processes which are affected in Parkinson's disease (PD), the possible importance of JNK in disease pathogenesis is being increasingly recognized. Here we review recent findings implicating the JNK signaling pathway in animal models of Parkinson's disease and discuss the relationship between this pathway and the prominent pathological processes observed in the disease state. We suggest that regulation of the JNK signaling pathway may be a central facet in potential treatments for the disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12880208     DOI: 10.1080/1521654031000121666

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  29 in total

1.  Intrahippocampal miR-342-3p inhibition reduces β-amyloid plaques and ameliorates learning and memory in Alzheimer's disease.

Authors:  Yin Fu; Xiaoyang Hu; Chunyu Zheng; Guicai Sun; Jianyu Xu; Shanshan Luo; Peigang Cao
Journal:  Metab Brain Dis       Date:  2019-05-27       Impact factor: 3.584

2.  Glutathione S-transferase pi mediates MPTP-induced c-Jun N-terminal kinase activation in the nigrostriatal pathway.

Authors:  Margarida Castro-Caldas; Andreia Neves Carvalho; Elsa Rodrigues; Colin Henderson; C Roland Wolf; Maria João Gama
Journal:  Mol Neurobiol       Date:  2012-04-27       Impact factor: 5.590

3.  c-Jun N-terminal kinase inhibitor SP600125 modulates the period of mammalian circadian rhythms.

Authors:  M Chansard; P Molyneux; K Nomura; M E Harrington; C Fukuhara
Journal:  Neuroscience       Date:  2007-01-30       Impact factor: 3.590

4.  Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson's disease.

Authors:  J K Morris; H Zhang; A A Gupte; G L Bomhoff; J A Stanford; P C Geiger
Journal:  Brain Res       Date:  2008-09-11       Impact factor: 3.252

Review 5.  The Role of Lipidomics in Autism Spectrum Disorder.

Authors:  Afaf El-Ansary; Salvatore Chirumbolo; Ramesa Shafi Bhat; Maryam Dadar; Eiman M Ibrahim; Geir Bjørklund
Journal:  Mol Diagn Ther       Date:  2020-02       Impact factor: 4.074

6.  Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway.

Authors:  Julie Lotharius; Jeppe Falsig; Johan van Beek; Sarah Payne; Ralf Dringen; Patrik Brundin; Marcel Leist
Journal:  J Neurosci       Date:  2005-07-06       Impact factor: 6.167

7.  Unraveling the neuroprotective mechanisms of PrP (C) in excitotoxicity.

Authors:  Franc Llorens; José Antonio Del Río
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

8.  Poly-PR in C9ORF72-Related Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Causes Neurotoxicity by Clathrin-Dependent Endocytosis.

Authors:  Rui Wang; Xingyun Xu; Zongbing Hao; Shun Zhang; Dan Wu; Hongyang Sun; Chenchen Mu; Haigang Ren; Guanghui Wang
Journal:  Neurosci Bull       Date:  2019-05-30       Impact factor: 5.203

9.  PDZ Scaffold Protein CAL Couples with Metabotropic Glutamate Receptor 5 to Protect Against Cell Apoptosis and Is a Potential Target in the Treatment of Parkinson's Disease.

Authors:  Wen Yuan Luo; Su Qian Xing; Ping Zhu; Chen Guang Zhang; Hui Min Yang; Nicholas Van Halm-Lutterodt; Li Gu; Hong Zhang
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

10.  Activation of c-Jun-N-terminal kinase and decline of mitochondrial pyruvate dehydrogenase activity during brain aging.

Authors:  Qiongqiong Zhou; Philip Y Lam; Derick Han; Enrique Cadenas
Journal:  FEBS Lett       Date:  2009-03-09       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.